.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Argus Health
Federal Trade Commission
Teva
Healthtrust
McKesson
Mallinckrodt
McKinsey
Merck
UBS

Generated: September 26, 2017

DrugPatentWatch Database Preview

DEPO-TESTOSTERONE Drug Profile

« Back to Dashboard

What is the patent landscape for Depo-testosterone, and what generic Depo-testosterone alternatives are available?

Depo-testosterone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-TESTOSTERONE is testosterone cypionate. There are sixty-one drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the testosterone cypionate profile page.

Summary for Tradename: DEPO-TESTOSTERONE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list37
Clinical Trials: see list777
Patent Applications: see list1,608
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEPO-TESTOSTERONE at DailyMed

Pharmacology for Tradename: DEPO-TESTOSTERONE

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DEPO-TESTOSTERONE
testosterone cypionate
INJECTABLE;INJECTION085635-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-TESTOSTERONE
testosterone cypionate
INJECTABLE;INJECTION085635-002Approved Prior to Jan 1, 1982AORXNoYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-TESTOSTERONE
testosterone cypionate
INJECTABLE;INJECTION085635-003Approved Prior to Jan 1, 1982AORXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Deloitte
Boehringer Ingelheim
Express Scripts
Chubb
AstraZeneca
Moodys
Teva
US Department of Justice
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot